
zzso zzso therapy has been shown promising in the treatment of several advanced zzso since the approval of the first zzso drug zzso in zzso Although the current zzso drugs reduce the density of tumor blood vessels and result in tumor shrinkage at the early stage of treatment, recent studies have shown that zzso therapy has transient and insufficient zzso resulting in tumor recurrence in patients after several months of zzso zzso of blood and oxygen supplies creates a hypoxic and zzso zzso in the tumor zzso which fosters tumor cells to become more aggressive and zzso In 2001, zzso proposed tumor vascular zzso as an alternative approach to treating zzso based on the pioneering work on tumor blood vessels by several other zzso At present, zzso the zzso tumor zzso rather than zzso or blocking them, has emerged as a new option for zzso zzso zzso and clinical data have shown that tumor vascular zzso using zzso zzso zzso zzso small zzso and zzso resulted in decreased tumor size and reduced zzso However, current tumor vascular zzso drugs display moderate zzso zzso zzso data have shown that a variety of zzso tumor cells and genes play important roles in tumor zzso growth, and zzso zzso zzso of zzso tumor cells and genes may improve the efficacy of tumor vascular zzso To this end, the combination of zzso drugs with tumor vascular zzso zzso as well as the integration of Western medicine with traditional Chinese medicine, may provide a good opportunity for discovering novel tumor vascular zzso drugs for an effective zzso zzso 

